The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism. 1961.
Birkmayer
W
W
Hornykiewicz
O
O
D000978:Antiparkinson Agents / Q000266:history* / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism / Q000503:physiopathology*; D004298:Dopamine / Q000266:history* / Q000378:metabolism; D049673:History, 20th Century; D006801:Humans; D007980:Levodopa / Q000266:history* / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy / Q000266:history* / Q000378:metabolism
D000978:Antiparkinson Agents; D007980:Levodopa; D004298:Dopamine